CN104844502A - 一种匹莫范色林的制备方法 - Google Patents
一种匹莫范色林的制备方法 Download PDFInfo
- Publication number
- CN104844502A CN104844502A CN201510306708.4A CN201510306708A CN104844502A CN 104844502 A CN104844502 A CN 104844502A CN 201510306708 A CN201510306708 A CN 201510306708A CN 104844502 A CN104844502 A CN 104844502A
- Authority
- CN
- China
- Prior art keywords
- preparation
- organic solvent
- compound
- formula
- fanselin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BGAUYHOUKFUXGT-UHFFFAOYSA-N CN(CC1)CCC1N(Cc(cc1)ccc1F)C(OC1CCCCC1)=O Chemical compound CN(CC1)CCC1N(Cc(cc1)ccc1F)C(OC1CCCCC1)=O BGAUYHOUKFUXGT-UHFFFAOYSA-N 0.000 description 1
- PLYWEOOWONUOBN-UHFFFAOYSA-N CN(CC1)CCC1NCc(cc1)ccc1F Chemical compound CN(CC1)CCC1NCc(cc1)ccc1F PLYWEOOWONUOBN-UHFFFAOYSA-N 0.000 description 1
- IWVJLGPDBXCTDA-UHFFFAOYSA-N O=C(OC1CCCCC1)Cl Chemical compound O=C(OC1CCCCC1)Cl IWVJLGPDBXCTDA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510306708.4A CN104844502B (zh) | 2015-06-05 | 2015-06-05 | 一种匹莫范色林的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510306708.4A CN104844502B (zh) | 2015-06-05 | 2015-06-05 | 一种匹莫范色林的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104844502A true CN104844502A (zh) | 2015-08-19 |
CN104844502B CN104844502B (zh) | 2018-07-31 |
Family
ID=53844542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510306708.4A Expired - Fee Related CN104844502B (zh) | 2015-06-05 | 2015-06-05 | 一种匹莫范色林的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104844502B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153016A (zh) * | 2015-10-12 | 2015-12-16 | 北京诺康达医药科技有限公司 | 一种匹莫范色林的制备方法 |
CN105481757A (zh) * | 2015-12-25 | 2016-04-13 | 北京康立生医药技术开发有限公司 | 一种哌马色林的制备方法 |
CN105929030A (zh) * | 2015-12-18 | 2016-09-07 | 重庆两江药物研发中心有限公司 | 一种哌马色林中有机杂质的检测方法 |
WO2017015272A1 (en) * | 2015-07-20 | 2017-01-26 | Acadia Pharmaceuticals Inc. | Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c |
CN106518751A (zh) * | 2015-09-11 | 2017-03-22 | 江苏先声药业有限公司 | 一种制备匹莫范色林的方法 |
WO2017054786A1 (en) * | 2015-10-02 | 2017-04-06 | Zentiva, K. S. | A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4-yl)urea and its deuterated analogs |
CN107286078A (zh) * | 2016-04-13 | 2017-10-24 | 广东东阳光药业有限公司 | 一种制备哌马色林及其酒石酸盐的方法 |
US10449185B2 (en) | 2017-08-30 | 2019-10-22 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
US10517860B2 (en) | 2016-03-25 | 2019-12-31 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
CN110938031A (zh) * | 2018-09-21 | 2020-03-31 | 浙江京新药业股份有限公司 | 匹莫范色林杂质及其制备方法 |
CN112119058A (zh) * | 2018-04-26 | 2020-12-22 | 欧伦股份公司 | 制备哌马色林碱的方法 |
US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
US11345693B2 (en) | 2017-08-21 | 2022-05-31 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
US11440884B2 (en) * | 2017-08-21 | 2022-09-13 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
US11464768B2 (en) | 2016-12-20 | 2022-10-11 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101031548A (zh) * | 2004-09-27 | 2007-09-05 | 阿卡蒂亚药品公司 | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n'-(4-(2-甲基丙氧基)-苯基甲基)脲的盐及其制备 |
WO2008141057A1 (en) * | 2007-05-08 | 2008-11-20 | Auspex Pharmaceuticals, Inc. | Deuterated pimavanserin 1- (4-flu0r0benzyl) -3- (4-isobutoxybenzyl) -1- ( l-methyl-piperidin-4-yl) -urea |
WO2009039461A2 (en) * | 2007-09-21 | 2009-03-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
CN101500568A (zh) * | 2006-05-15 | 2009-08-05 | 阿卡蒂亚药品公司 | 匹莫范色林的药物制剂 |
CN101619043A (zh) * | 2008-06-30 | 2010-01-06 | 和记黄埔医药(上海)有限公司 | 喹唑啉衍生物及其医药用途 |
-
2015
- 2015-06-05 CN CN201510306708.4A patent/CN104844502B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101031548A (zh) * | 2004-09-27 | 2007-09-05 | 阿卡蒂亚药品公司 | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n'-(4-(2-甲基丙氧基)-苯基甲基)脲的盐及其制备 |
CN101500568A (zh) * | 2006-05-15 | 2009-08-05 | 阿卡蒂亚药品公司 | 匹莫范色林的药物制剂 |
WO2008141057A1 (en) * | 2007-05-08 | 2008-11-20 | Auspex Pharmaceuticals, Inc. | Deuterated pimavanserin 1- (4-flu0r0benzyl) -3- (4-isobutoxybenzyl) -1- ( l-methyl-piperidin-4-yl) -urea |
WO2009039461A2 (en) * | 2007-09-21 | 2009-03-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
CN101619043A (zh) * | 2008-06-30 | 2010-01-06 | 和记黄埔医药(上海)有限公司 | 喹唑啉衍生物及其医药用途 |
Non-Patent Citations (1)
Title |
---|
JENNIFER A. MAIER,等: "Development of N-2,4-pyrimidine-N-phenyl-N’-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11840515B2 (en) | 2015-07-20 | 2023-12-12 | Acadia Pharmaceuticals Inc. | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c |
US10981871B2 (en) | 2015-07-20 | 2021-04-20 | Acadia Pharmaceuticals Inc. | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C |
US10981870B2 (en) | 2015-07-20 | 2021-04-20 | Acadia Pharmaceuticals Inc. | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form |
WO2017015272A1 (en) * | 2015-07-20 | 2017-01-26 | Acadia Pharmaceuticals Inc. | Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c |
US10597363B2 (en) * | 2015-07-20 | 2020-03-24 | Acadia Pharmaceuticals Inc. | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C |
CN106518751A (zh) * | 2015-09-11 | 2017-03-22 | 江苏先声药业有限公司 | 一种制备匹莫范色林的方法 |
CN106518751B (zh) * | 2015-09-11 | 2021-05-04 | 江苏先声药业有限公司 | 一种制备匹莫范色林的方法 |
WO2017054786A1 (en) * | 2015-10-02 | 2017-04-06 | Zentiva, K. S. | A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4-yl)urea and its deuterated analogs |
CN105153016A (zh) * | 2015-10-12 | 2015-12-16 | 北京诺康达医药科技有限公司 | 一种匹莫范色林的制备方法 |
CN105929030B (zh) * | 2015-12-18 | 2018-08-21 | 重庆两江药物研发中心有限公司 | 一种哌马色林中有机杂质的检测方法 |
CN105929030A (zh) * | 2015-12-18 | 2016-09-07 | 重庆两江药物研发中心有限公司 | 一种哌马色林中有机杂质的检测方法 |
CN105481757A (zh) * | 2015-12-25 | 2016-04-13 | 北京康立生医药技术开发有限公司 | 一种哌马色林的制备方法 |
US10517860B2 (en) | 2016-03-25 | 2019-12-31 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
US11191757B2 (en) | 2016-03-25 | 2021-12-07 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
CN107286078A (zh) * | 2016-04-13 | 2017-10-24 | 广东东阳光药业有限公司 | 一种制备哌马色林及其酒石酸盐的方法 |
US11464768B2 (en) | 2016-12-20 | 2022-10-11 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis |
US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
US11345693B2 (en) | 2017-08-21 | 2022-05-31 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
US11440884B2 (en) * | 2017-08-21 | 2022-09-13 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
US10849891B2 (en) | 2017-08-30 | 2020-12-01 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
US10646480B2 (en) | 2017-08-30 | 2020-05-12 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
US11452721B2 (en) | 2017-08-30 | 2022-09-27 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
US10449185B2 (en) | 2017-08-30 | 2019-10-22 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
CN112119058A (zh) * | 2018-04-26 | 2020-12-22 | 欧伦股份公司 | 制备哌马色林碱的方法 |
CN110938031A (zh) * | 2018-09-21 | 2020-03-31 | 浙江京新药业股份有限公司 | 匹莫范色林杂质及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104844502B (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104844502A (zh) | 一种匹莫范色林的制备方法 | |
CA2667416C (en) | Process for making crystalline anhydrous docetaxel | |
CN1246864A (zh) | 3'-n-氧化物、3'-n-二甲胺、9-肟红霉素a衍生物 | |
WO2019026014A1 (en) | METHODS FOR PREPARING LIFITEGRAST AND ITS INTERMEDIATES | |
CN102731491B (zh) | 一种阿齐沙坦中间体的制备方法 | |
CN106279104B (zh) | 一种制备琥珀酸曲格列汀的工艺改进方法 | |
WO2016193482A1 (en) | Process for preparing clobazam using novel intermediates | |
CN103450148A (zh) | 一种五元环硫酸酯化合物的合成方法 | |
CN103232475B (zh) | 一种阿扑西林三水合物的制备方法 | |
CN105713068B (zh) | 一种制备咪达普利关键中间体及其衍生物的方法 | |
CN104910068B (zh) | 一种2‑氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法 | |
CN109232457A (zh) | 一种利奈唑胺的制备方法 | |
CN110684039B (zh) | 一种头孢西丁内酯物的制备方法 | |
CN103130700A (zh) | 一种阿折地平中间体的制备方法 | |
CN102432616B (zh) | 一种制备l-脯氨酰胺及其中间体的方法 | |
US9169221B2 (en) | Dihydro 1,4-benzoxazines and method of synthesizing the same using sulfonium salts | |
CN101979393A (zh) | 一种由7-aca合成头孢噻吩酸的方法 | |
WO2008075834A1 (en) | Method of preparing taxane derivatives and intermediates used therein | |
CN103922985B (zh) | 一种氮杂环丁酮的合成方法 | |
CN111233921A (zh) | 新化合物及其用于合成磷霉素杂质d的方法 | |
CN115160217B (zh) | 一种吡仑帕奈的制备方法、合成中间体及降解杂质的制备方法 | |
BRPI0711805A2 (pt) | processo para a preparação de um derivado de taxano | |
CN101654426A (zh) | 制备伊洛马司他的方法 | |
CN104163803B (zh) | 一种头孢洛林酯的合成方法 | |
CN103396380A (zh) | 一种头孢洛林侧链酸反式体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Peifu Inventor before: Jiao Peifu Inventor before: Geng Qiaohong Inventor before: Li Chencan Inventor before: Feng Shuming |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180508 Address after: 250200 Wen Bo Road, Zhangqiu District, Ji'nan, Shandong Province, No. 2 Applicant after: QILU NORMAL UNIVERSITY Address before: 250101 B0305-1 11, 101 Shun Feng Road, Ji'nan hi tech Zone, Shandong. Applicant before: Jinan Tao Rui Pharmaceutical Technology Co., Ltd |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180731 Termination date: 20190605 |
|
CF01 | Termination of patent right due to non-payment of annual fee |